Lysosomal membrane permeabilization during apoptosis - involvement of Bax?

• Published in: International journal of experimental pathology 2005-10, Vol.86 (5), p.309-321
• Main Authors: Kågedal, Katarina, Johansson, Ann-Charlotte, Johansson, Uno, Heimlich, Gerd, Roberg, Karin, Wang, Nancy S., Jürgensmeier, Juliane M., Öllinger, Karin
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis - physiology; Bax; Biological and medical sciences; Biological Transport; Blotting, Western; Cathepsin D - metabolism; cathepsins; Cell Line; Enzyme Inhibitors - pharmacology; Fibroblasts - metabolism; Fibroblasts - pathology; Humans; Immunohistochemistry - methods; Intracellular Membranes - chemistry; Intracellular Membranes - drug effects; Intracellular Membranes - metabolism; Investigative techniques, diagnostic techniques (general aspects); Liver - metabolism; Liver - ultrastructure; lysosomal membrane permeabilization; lysosomes; Lysosomes - metabolism; Medical sciences; MEDICIN; MEDICINE; Microscopy, Confocal; Microscopy, Immunoelectron; mitochondria; Original; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Permeability - drug effects; Protein Kinase C - antagonists & inhibitors; Rats; Rats, Sprague-Dawley; Staurosporine - pharmacology
• ISSN: 0959-9673; 1365-2613; 1365-2613
• DOI: 10.1111/j.0959-9673.2005.00442.x

Summary Bcl‐2 family members have long been known to control permeabilization of the mitochondrial membrane during apoptosis, but involvement of these proteins in lysosomal membrane permeabilization (LMP) was not considered until recently. The aim of this study was to investigate the mechanism underlying the release of lysosomal proteases to the cytosol seen during apoptosis, with special emphasis on the role of Bax. In human fibroblasts, exposed to the apoptosis‐inducing drug staurosporine (STS), the release of the lysosomal protease cathepsin D to the cytosol was observed by immunocytochemistry. In response to STS treatment, there was a shift in Bax immunostaining from a diffuse to a punctate pattern. Confocal microscopy showed co‐localization of Bax with both lysosomes and mitochondria in dying cells. Presence of Bax at the lysosomal membrane was confirmed by immuno‐electron microscopy. Furthermore, when recombinant Bax was incubated with pure lysosomal fractions, Bax inserted into the lysosomal membrane and induced the release of lysosomal enzymes. Thus, we suggest that Bax is a mediator of LMP, possibly promoting the release of lysosomal enzymes to the cytosol during apoptosis.